gatifloxacin has been researched along with Pseudophakia in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Pseudophakia: Presence of an intraocular lens after cataract extraction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " With both dosing regimens, the mean vitreous concentration of moxifloxacin 0." | 2.72 | Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. ( Bakri, SJ; Beer, PM; Costello, P; Falk, NS; Melendez, JA; Peters, GB; Singh, RJ, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costello, P | 1 |
| Bakri, SJ | 1 |
| Beer, PM | 1 |
| Singh, RJ | 1 |
| Falk, NS | 1 |
| Peters, GB | 1 |
| Melendez, JA | 1 |
1 trial available for gatifloxacin and Pseudophakia
| Article | Year |
|---|---|
Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Biological A | 2006 |